Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer.
暂无分享,去创建一个
P. Neven | P. Goss | Bing-he Xu | I. Láng | B. Moy | E. Leip | M. Bellet | L. Chow | F. Lebrun | C. Zacharchuk | N. Bardy-Bouxin | K. Turnbull | L. Duvillié | T. Sarosiek